Leerink Partners analyst Andrew Berens has maintained their bullish stance on AZN stock, giving a Buy rating on November 6. Andrew ...

AstraZeneca (GB:AZN) has released an update. AstraZeneca’s Tezspire has shown promising results in the Phase III WAYPOINT trial, ...

AstraZeneca said on Wednesday its China president Leon Wang had been detained by Chinese authorities and, although it did not ...

AstraZeneca said on Monday its experimental weight-loss pill, licensed from China's Eccogene, was safe and tolerable in an ...

AstraZeneca is a company with a turbulent history but, for now, a promising future. We take a look at the company's story, from its creation as a merger of two equals, to its recent major ...

Drug maker has yet to elaborate whether Leon Wang is in custody, nor have his whereabouts been disclosed AstraZeneca's China ...

AstraZeneca said on Wednesday that to its knowledge an ongoing investigation by Chinese authorities into the company's top executive in the country, Leon Wang, is separate from a large health ...

AstraZeneca said on Wednesday the company's China President Leon Wang is currently under investigation and is cooperating ...

CEO Pascal Soriot said AstraZeneca complies with Chinese policies and works closely with authorities following the detention. As per a financial media company Yicai report, senior executives at ...

AstraZeneca's (NASDAQ:AZN) selloff on Tuesday in response to reports that the company is facing a fraud investigation in China highlights how much value the Anglo-Swedish pharma giant has attached ...

AstraZeneca and Honeywell are developing MDIs that will use a new propellant called HFO-1234ze, which, according to the company, has 99.9% less Global Warming Potential (GWP) than existing ...

AstraZeneca Plc said its experimental obesity ... of their body weight over four weeks in an early study, the UK pharma company reported at the ObesityWeek conference in San Antonio, Texas.